Schedule 13D ownership disclosure

Orchestra BioMed Holdings Inc

Common Stock, par value $0.0001 per share · CUSIP: 68572M106

Event date: 2025-04-29

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RTW Investments, LPReported CIK 0001493215

    Shares: 8,306,063 · Class: 21.7%

  • RTW Master Fund, Ltd.Reported CIK 0001493219

    Shares: 4,394,985 · Class: 11.5%

  • RTW Innovation Master Fund, Ltd.Reported CIK 0001776733

    Shares: 3,053,082 · Class: 8.0%

  • Roderick Wong, M.D.Reported CIK 0001493280

    Shares: 8,306,063 · Class: 21.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-062060
Form type
SCHEDULE 13D/A
Filer
Orchestra BioMed Holdings, Inc.
CIK
CIK 1814114
Filed
May 01, 2025
Reporting period
Apr 29, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub